We are pleased to announce that patients from Britain now have representation within the International Association for Cannabinoid Medicines (IACM). Our aim is to to expand knowledge of cannabinoids and the growing, fertile area of study that has emerged from an abundance of scientific research. The IACM supports research into the therapeutic uses of cannabinoids, in addition, we also provide annecdotal evidence of the effectiveness of cannabinoids on patients with chronic conditions. The British representative is Sarah Martin and we will soon update this information to include her full contact details. She will be available for talks and presentations throughout Europe.
To join, please refer to the main IACM website here